








































Journal Compilation © 2017 Foundation of Rehabilitation Information. ISSN 1650-1977
This is an open access article under the CC BY-NC license. www.medicaljournals.se/jrm
doi: 10.2340/16501977-2168
ORIGINAL REPORT
J Rehabil Med 2017; 49: 40–48
USE OF NEUROMUSCULAR ELECTRICAL STIMULATION TO PRESERVE THE 
THICKNESS OF ABDOMINAL AND CHEST MUSCLES OF CRITICALLY ILL 
PATIENTS: A RANDOMIZED CLINICAL TRIAL
Ana M. DALL’ ACQUA, PT, MSc1*, Amanda SACHETTI, PT, MSc2*, Laura J. SANTOS, PT, ScD3*, Fernando A. LEMOS, 
ScD4*, Tanara BIANCHI, PT, MSc2*, Wagner S. NAUE, PT, ScD5*, Alexandre S. DIAS, PT, PhD6,7*, Graciele SBRUZZI, 
PT, ScD7*, Silvia R. R. VIEIRA, MD, PhD8* and MoVe-ICU Group
From the 1Program in Health Sciences, Cardiology and Cardiovascular Sciences, 2Program in Respiratory Sciences, Universidade Federal 
do Rio Grande do Sul (UFRGS), 3Physiotherapy Course, Universidade Luterana do Brasil (ULBRA, Canoas/RS, 4Program in Sciences of 
Human Movement, UFRGS, 5Unit of Physical Therapy – Department of Intensive Medicine, Hospital de Clínicas de Porto Alegre (HCPA), 
6Physiotherapy Course, UFRGS, Physiotherapy Service, HCPA, 7Graduate Program in Sciences of Human Movement, UFRGS, Graduate 
Program in Respiratory Sciences, UFRGS, 8School of Medicine (FAMED), UFRGS, Service of Intensive Medicine, HCPA, Porto Alegre/RS, 
Brazil. *These authors contributed equally to this work.
Objective: To evaluate and compare the effects of 
neuromuscular electrical stimulation combined with 
conventional physical therapy on muscle thickness 
in critically ill patients. Design: Double-blind, ran-
domized controlled trial. 
Patients: Twenty-five patients participated in the 
study. 
Methods: Patients on mechanical ventilation for 
24–48 h were randomized to an intervention group 
(neuromuscular electrical stimulation + conventio-
nal physical therapy) or a conventional group (sham 
neuromuscular electrical stimulation + conventional 
physical therapy). Primary outcome was thickness 
of the rectus abdominis and chest muscles, determi-
ned on cross-sectional ultrasound images before and 
after the intervention. 
Results: Eleven patients were included in the in-
tervention group and 14 in the conventional group. 
After neuromuscular electrical stimulation, rec-
tus abdominis muscle thickness and chest muscle 
thickness were preserved in the intervention group, 
whereas there was a significant reduction in thick-
ness in the conventional group, with a significant 
difference between groups. There was a significant 
difference between groups in length of stay in the 
intensive care unit, with shorter length of stay in the 
intervention group. 
Conclusion: There was no change in rectus abdomi-
nis and chest muscle thickness in the intervention 
group. A significant decrease was found in these 
measures in the conventional group.
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sive care unit.
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Intensive care units (ICUs) focus on treating criti-cally ill patients. The mortality rate in these units in 
Brazil ranges from 5.4% to 33% (1, 2). According to 
the 2nd Brazilian Census of ICUs, the mean length of 
ICU stay ranges from 1 to 6 days (3) and, according 
to Williams et al. (4), the worldwide mean length of 
ICU stay is 5.3 days.
Seriously ill patients are often exposed to prolonged 
immobilization, which contributes to the development 
of neuromuscular complications (5, 6). Patients who 
stay in bed for long periods of time are prone to de-
velop skeletal muscle weakness, leading to muscle 
atrophy and a loss of 3–11% of muscle mass in the first 
3 weeks of immobilization (7). Such loss of muscle 
mass and muscle weakness are caused by acquired 
myopathy, polyneuropathy, or a combination of both 
(8). The development of polyneuropathy worsens the 
functional status of ICU patients, affecting 25–100% 
of patients ventilated for more than 7 days (9), with 
a prevalence of 58–96% of ICU patients (10). Two 
large studies evaluated survivors of acute respiratory 
distress syndrome at 3, 6 and 12 months and at 2, 3, 
4 and 5 years after discharge from the ICU, and con-
cluded that these patients have persistent functional 
disability 1 year after discharge from the ICU, and 
that most patients have extrapulmonary conditions, 
with muscle weakness and loss of muscle mass being 
most prominent (11, 12).
Neuromuscular electrical stimulation (NMES) is 
effective in the treatment of deficient muscles (13, 
14). NMES is able to preserve muscle protein syn-
thesis and prevent muscle atrophy during prolonged 
immobilization (15). Recently, NMES has been used 
to treat polyneuropathy in ICUs. This technique does 
not require active cooperation of the patient, and has a 
beneficial acute systemic effect on skeletal muscle mi-
crocirculation (16), offering structural and functional 
advantages to critically ill patients. Studies involving 
critically ill patients with chronic conditions, such as 
congestive heart failure and chronic respiratory fai-
lure, have suggested that NMES is safe and effective, 
improving peripheral (17, 18) and respiratory muscle 









































41NMES to preserve muscle thickness in critically ill patients
Muscle cross-sectional area and/or thickness are 
strongly associated with force-generation capacity. 
However, few studies have been conducted in ICUs, 
especially involving trunk muscles, such as abdominal 
and chest muscles. Studies on NMES have suggested 
that this technique is useful in medical practice, with 
the purpose of preventing or decreasing loss of muscle 
mass and peripheral muscle atrophy in this population 
(23, 24). We could not find reports of its benefits in 
core muscle groups, such as the ones investigated in 
our study, as we know that loss of muscle mass does 
not affect only peripheral muscles. There is also mass 
loss in respiratory muscles, especially when patients 
cannot move and receive invasive mechanical venti-
lation (IMV). In these cases, the pectoralis major and 
the abdominal muscle have their alterations evaluated 
because they participate in the respiratory mechanism. 
To date, we could not find any descriptions of these 
alterations in the literature. Therefore, the main objec-
tive of the present study was to evaluate the effects of 
NMES combined with conventional physical therapy 
on rectus abdominis and chest muscle thickness com-
pared with sham NMES combined with conventional 
physical therapy in patients receiving IMV. 
METHODS
This study was conducted in accordance with the principles of 
the Declaration of Helsinki and Good Clinical Practice. The 
procedures were performed in compliance with Resolution No. 
466/12 of the Brazilian National Health Council. The study 
was approved by the research ethics committee of Hospital 
de Clínicas de Porto Alegre (HCPA No. 353.996). The trial is 
registered at ClinicalTrials.gov (NCT 02298114). The patients’ 
legal guardians signed an informed consent form.
Study design and patients
A double-blind study (for outcome assessors and patients), 
with a per-protocol analysis, was conducted from August 2013 
to August 2014 at the HCPA ICU. Eligible participants were 
all patients (both female and male, aged ≥ 18 years) who had 
been hospitalized for no longer than 15 days and had received 
at least 24 h of IMV. Exclusion criteria were: patients with 
neuromuscular diseases, such as stroke, multiple sclerosis, 
amyotrophic lateral sclerosis, myasthenia gravis, and Guillain-
Barré syndrome, associated with motor deficits. In addition, 
patients were excluded if they: (i) were extubated within 48 h 
after inclusion in the study; (ii) had complications during the 
protocol, such as pneumothorax; (iii) had prolonged weaning 
(failed 3 spontaneous breathing trials); (iv) had a body mass 
index (BMI) > 35 kg/m2; (v) had a pacemaker; (vi) had hae-
modynamic instability (noradrenaline > 0.5 µg/kg/min for a 
mean arterial pressure > 60 mmHg) with a history of epilepsy 
or postoperatively with abdominal or chest incision; and (vii) 
used neuromuscular blockers for 2 or more consecutive days.
Sample selection
An assessor searched for potential trial participants via the 
HCPA’s computerized system. Patients’ electronic medical re-
cords were reviewed for identification data, medical diagnosis, 
and current medical conditions to assess patients for eligibility. 
The legal guardian of each eligible patient was approached for 
study enrollment, and those who agreed to participate were 
asked to sign the informed consent form.
Randomization
A randomization sequence was created using the website www.
randomization.com, with a 1:1 allocation ratio using blocks 
of 10 patients. To ensure confidentiality of the randomization 
sequence, it was generated by a blinded assessor who was con-
tacted via telephone only after the participant had been included 
in the study and was ready to start the protocol.
Patients were randomly assigned to receive either 
NMES + conventional physical therapy (intervention group) 
or sham NMES + conventional physical therapy (conventional 
group). The NMES group received NMES for 30 min once a 
day + conventional physical therapy, whereas the conventional 
group received sham NMES for 30 min once a day + conven-
tional physical therapy. The protocol was interrupted on day 7, 
when the patient was extubated, or if the patient died (whiche-
ver occurred first). NMES was administered in both groups by 
previously trained professionals for procedure standardization. 
Conventional physical therapy in both groups was performed 
by ICU professionals twice a day. 
Outcomes
The primary outcome was the difference in rectus abdominis 
and chest muscle thickness of the dominant side from initial 
to final assessment between groups. Secondary outcomes in-
cluded changes in diaphragm muscle thickness, and inhaling 
and exhaling diaphragmatic motion. Length of stay in the ICU 
and in the hospital, duration of IMV, successful extubation and 
death were also assessed.
Evaluation of outcomes
After inclusion in the trial and before starting the protocol, all 
participants underwent ultrasound of the chest and abdominal 
muscles for assessment of muscle thickness and diaphragmatic 
motion. Ultrasound examination was performed on 2 different 
occasions: on the first day of participation in the study (24–48 
h of IMV) and on day 7 of IMV or 24 h after extubation.
Evaluation of muscle thickness
Muscle thickness was determined on cross-sectional ultrasound 
images. With the patient lying supine and the head of the bed 
elevated at 30°, real-time B-mode scanning was performed using 
a 3.5-mm, 7.5 MHz linear-array transducer (Sonosite®, Wash-
ington, DC, USA). The scanning head was coated with water-
soluble transmission gel to provide acoustic contact without 
depressing the dermal surface. The sites for image acquisition 
were determined using anatomical parameters reported in the 
literature (25). To assess the chest muscle, the midpoint of the 
sternum was determined. Starting at this point, the transducer 
was positioned obliquely toward the nipple line, seeking to reach 









































42 A.M. Dall’ Acqua et al.
an area of larger muscle belly. To assess the rectus abdominis 
muscle, we obtained the measure at a lateral distance of 2 cm 
from the umbilicus.
After the sites were marked on the skin, a cross-sectional 
image was acquired, which included the chest and rectus abdo-
minis muscles. Because the transducer is 3.5 cm long, muscle 
thickness was adopted as the preferred measure, as it was not 
always possible to capture the total area of the rectus abdominis 
muscles. Thus, muscle thickness was determined based on mea-
surements performed between the inner edge of the upper and 
lower aponeuroses of the chest and rectus abdominis muscles. 
The specific measure of the rectus abdominis muscles was col-
lected during maximal inspiration, because there is a dynamic 
change in the thickness of the muscle due to the movement of 
the abdomen during breathing. Five measurements were taken 
based on each image. A mean measurement was determined to 
establish the muscle thickness.
For ultrasound-based measurement of diaphragmatic muscle 
thickness, the patient was placed in the supine position. The 
transducer was positioned perpendicularly to the diaphragm in 
the intercostal space over the tenth rib on the anterior axillary 
line, the image was acquired and the thickness was measured 
at the end of inspiration.
For assessment of diaphragmatic motion, the ultrasound 
transducer was positioned through the anatomical window 
provided by the liver between the mid-clavicular position and 
the anterior axillary line towards the skull. Thus, the transducer 
was placed in a medial, cranial, and dorsal position, making it 
possible for the ultrasound beam to reach the posterior third of 
the diaphragm (26, 27).
Inhalation and exhalation diaphragmatic excursion was mea-
sured on M-mode ultrasound images. The inhalation excursion 
was determined by measuring the vertical height of the base 
of the beginning of inhalation up to the peak slope at the end 
of inhalation, and the exhalation excursion was determined 
by measuring the vertical height of the inhalation peak until 
return to the base.
The muscle ultrasound examination was repeatedly assessed 
on 2 separate days, based on 10 images for each region. The 
intraclass correlation coefficient for the test-retest muscle thick-
ness measurements was r = 0.996 for the chest muscle, r = 0.998 
for the rectus abdominis, r = 0.972 for the diaphragmatic muscle 
thickness, and r = 0.985 for the diaphragmatic excursion. All 
ultrasound examinations were performed by the same highly 
experienced professional (4 years), who was blinded to group 
assignment. All ultrasound measurements were expressed in cm. 
Fig. 1 shows a representative transducer position.
Interventions
In the intervention group, NMES was performed using a 4-chan-
nel Neurodyn II (Ibramed®, São Paulo, SP, Brazil). Only the 
dominant side of each patient was considered for analysis, 
and hairy body areas were shaved, as necessary. The negative 
electrodes were placed in the motor points of the following mus-
cles: chest muscles (pectoralis major muscle fibres) and rectus 
abdominis muscles bilaterally. A second (positive) electrode 
was positioned distally to the first, at a site close to the muscle 
that was being electrically stimulated, totalling 1 channel with 
2 electrodes for each muscle (Fig. 2). 
Each NMES session lasted 30 min. One minute was added 
every 2 days of administration. The following parameters were 
used: 50 Hz frequency, pulse duration 300 ms, rise time 1 s, sti-
mulus time (ON) 3 s, decay time 1 s, and relaxation time (OFF) 
10 s. Intensity was increased until muscle contraction was visible 
or could be identified through palpation. In conscious patients, 
intensity was adjusted according to their tolerance (23, 24).
The conventional group received sham NMES following the 
same protocol applied to the intervention group. The procedure 
was blinded; however, the intensity was adjusted at a sensory 
Fig. 2. Representative image of the positioning of electrodes on the 
straight muscles of the abdomen and chest to perform the protocol.











































43NMES to preserve muscle thickness in critically ill patients
level, i.e. without visible or palpable muscle contractions. The 
standard maximum intensity in this group was 5 mA. 
Conventional (chest and motor) physical therapy was admi-
nistered in both groups by ICU professionals twice daily for 30 
min. The protocol consisted of functional-diagonal movements 
based on the proprioceptive neuromuscular facilitation (PNF) 
stretching technique for the upper and lower extremities (2 sets 
of 10 repetitions per set of each diagonal movement bilaterally). 
At first, physical therapy was administered in a passive manner 
if the patient was sedated. The exercises evolved to assisted 
movements and active resisted movements according to the 
patient’s cooperation. Manual bronchial hygiene techniques 
were performed, such as chest compression-vibrations, mano-
euvres with an Ambu bag (bag-squeezing), and suction of 
secretions when necessary.
The protocols were initiated after the baseline evaluation 
within the first 48 h of IMV. During protocol administration, 
the following parameters were monitored in both groups: heart 
rate, respiratory rate, mean blood pressure, peripheral oxygen 
saturation, and ventilatory frequency. 
On day 7 of the protocol or upon extubation (whichever 
occurred first), all patients were assessed again by ultrasound 
and continued to receive only conventional (chest and motor) 
physical therapy provided by the ICU professionals until ICU 
discharge.
Sample size calculation 
The sample size calculation was based on a pilot study of 10 
patients for the variable cross-sectional area of abdominal and 
chest muscle thickness using the statistical program Winpepi. 
These measures were adjusted using a delta value, defined as 
the measures of final muscle thickness subtracted from the ba-
seline measures divided by the number of days the participant 
remained in the protocol. For an effect 
size of 0.7 standard deviations (SD) 
between the 2 groups, with a 5% signifi-
cance level and power of 80%, a sample 
size of 18 patients (9 patients per group) 
was required.
Statistical analysis
Data storage, arrangement, and mainte-
nance were performed using a MS Excel 
2007 spreadsheet. Data were expressed 
as mean and SD. Student’s t-test for in-
dependent samples was used to compare 
the means, and the χ2 test or Fisher’s 
exact (when more than 25% of the cells 
had the expected frequency < 5) were 
used to compare means between groups 
for qualitative data. The Shapiro–Wilk 
test was used to test the normality of 
distribution, and Levene’s test was used 
to assess homogeneity of variance for 
all group comparisons. A generalized 
estimating equations (GEE) model with 
Bonferroni’s correction was used to as-
sess intra- and inter-group interaction 
for primary and secondary outcomes. In 
the GEE model, possible confounding 
factors were controlled by adjusting for 
septic and non-septic patients, Acute 
Physiology and Chronic Health Disease 
Classification System II (APACHE II) score > 25 and < 25 end 
ICU stay. Statistical analysis was performed using SPSS, version 
20.0. The level of significance was set at 5% (p ≤ 0.05).







(n = 14) p-value
Age, years, mean (SD) 56 (13) 61 (15) 0.436
Sex, n (%) 1.000
Female 4 (36.3) 5 (35.7)
Male 7 (63.7) 9 (64.3)
kg/m2, mean (SD) 25 (4) 24 (5) 0.687
Laterality, n (%) 0.604
Right-handed 10 (90.9) 11 (78.5)
Left-handed 1 (9.1) 3 (21.5)
APACHE II, mean (SD) 26 (5) 29 (7) 0.206
Continued sedation, days, mean 
(SD)
2 (1) 3 (2) 0.845
Haemodialysis, n (%) 8 (73) 5 (43) 0.227
NMES duration, days, mean (SD) 5 (2) 5 (2) 0.889
ICU stay, days, mean (SD) 10 (4) 16 (9) 0.045*
MV time, days, mean (SD) 7 (2) 8 (3) 0.607
Re-intubation rate, n (%) 3 (25) 5 (38) 1.000
Deaths, n (%) 3 (27) 3 (21) 1.000
Reason for ICU admission, n
Sepsis 7 8 
ALE 1 2 
Other 3 4 
p-value was calculated using Student’s t-test for quantitative data and the χ2 
test or Fisher’s exact test for qualitative data (p > 0.05). SD: standard deviation; 
ICU: intensive care unit; MV: mechanical ventilation; NMES: neuromuscular 
electrical stimulation; APACHE II: Acute Physiology and Chronic Health Disease 
Classification System II; ALE: acute lung oedema; BMI: body mass index.
Fig. 3. Study flowchart. Encephalic vascular accident (EVA).
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RESULTS
From August 2013 to August 2014, 1,321 patients 
were screened for eligibility. Of these, 1,283 were 
not eligible for the study. Thirty-eight patients were 
randomized to the intervention group (n = 19) and 
to the conventional group (n = 19). Eleven patients 
in the intervention group and 14 in the conventional 
group completed the protocol and were included in the 
final analysis. Fig. 3 shows the flow of participants, 
including losses to follow-up and exclusions after 
randomization. 
Table I shows the characteristics of the study sample. 
Table II describes the comparison between the base-
line measurements of muscle thickness between the 




in mean between 
groups (95% CI) pa
Intervention 
group (n = 11)
Conventional 
group (n = 14)
Mean (SD) Mean (SD)
CT 0.44 (0.28) 0.42 (0.18) 0.02 (–0.22 to 0.27) 1.000
AT 0.47 (0.29) 0.43 (0.19) 0.04 (–0.22 to 0.29) 1.000
IDM 0.36 (0.18) 0.46 (0.29) 0.10 (–0.34 to 0.14) 1.000
EDM 0.23 (0.15) 0.35 (0.27) 0.12 (–0.33 to 0.10) 0.970
DT 0.28 (0.19) 0.20 (0.05) 0.08 (–0.06 to 0.23) 0.671
aIntergroup effect using a generalized estimating equations (GEE) model with 
Bonferroni’s correction. All ultrasound measurements were expressed in cm. 
95% CI: 95% confidence interval; SD: standard deviation; CT: chest muscle 
thickness; AT: abdominal muscle thickness; IDM: inhaling diaphragmatic 
motion; EDM: exhaling diaphragmatic motion. DT: diaphragm muscle thickness. 









in mean (95% CI) p-valuea
Interaction effect 
(group vs time)




p-valuebMean (SD) Mean (SD) Mean (SD) Mean (SD)
CT 0.44 (0.28) 0.49 (0.28) 0.05 (–0.00 to 0.10) 0.083 0.42 (0.17) 0.35 (0.16) –0.06 (–0.10 to –0.02) < 0.001 0.11 (0.04 to 0.18) < 0.001
AT 0.47 (0.28) 0.51 (0.26) 0.04 (–0.02 to 0.10) 0.505 0.43 (0.19) 0.36 (0.17) –0.07 (–0.10 to –0.04) < 0.001 0.09 (0.06 to 0.12) < 0.001
aIntra-group effect using a generalized estimating equations (GEE) model with Bonferroni’s correction; bintergroup effect using a generalized estimating equations 
(GEE) model with Bonferroni’s correction adjusted for APACHE II, sepsis end ICU stay. All ultrasound measurements expressed in cm. 
CT: chest muscle thickness; AT: abdominal muscle thickness; 95% CI: 95% confidence interval; SD: standard deviation. 
Fig. 4. Individual behaviour of the thickness of chest and abdominal muscles at baseline and at the end of the study for each group. (A) Variation 
in chest muscle thickness (CT) in the intervention group. (B) Variation in abdominal muscle thickness (AT) in the intervention group. (C) Variation 










































45NMES to preserve muscle thickness in critically ill patients
groups, showing that there was no statistical difference 
between the groups in terms of measurements of chest 
and abdominal muscles at baseline. 
The intensity in the intervention group caused pal-
pable or visible contraction in 100% of patients. The 
mean stimulation on the major pectoralis was 53 mA 
(SD 15), whereas it was 68 mA (SD 18) on the abdo-
minal muscle. In the control group, which received 
placebo NMES, the stimulation for all patients was 
up to 5 mA, not causing visible or palpable contrac-
tion in the patients. During administration of NMES, 
there were no complications or significant changes in 
vital signs.
Primary outcomes
There was a statistically significant difference between 
the intervention and conventional groups in abdominal 
and chest muscle thickness (p > 0.001). Considering the 
comparison between the initial and final assessment 
within each group, there was no change in muscle 
mass in the intervention group, whereas there was a 
statistically significant decrease in these measures in 
the conventional group (p > 0.001). Even after adjusting 
for potential confounders (sepsis and APACHE II), 
the results remained significant (p < 0.001) (Table III 
and Fig. 4). The effect size for chest muscle thickness 
and abdominal muscle thickness was 1 and 0.9 SD, 
respectively.
Secondary outcomes
There was a significant difference in length of ICU 
stay, which was shorter in the intervention group than 
in the conventional group (p = 0.045). There was no 
statistically significant difference in diaphragm muscle 
thickness or inhaling and exhaling diaphragmatic mo-
tion between the 2 groups. Likewise, the comparison 
between baseline and end evaluation within each group 
showed no significant differences. Even after adjusting 
for APACHE II and sepsis, the values remained non-
significant (p > 0.05) (Table IV). The effect size for 
inhaling diaphragmatic motion, exhaling diaphragma-
tic motion and diaphragm muscle thickness was 0.7, 
0.6, and 0.02 SD, respectively.
DISCUSSION
This study demonstrated that intervention using NMES 
combined with conventional physical therapy preser-
ved the chest and rectus abdominis muscle thickness 
in critically ill patients on IMV. This finding is con-
sistent with those reported by Gerovasili et al. (28), 
who evaluated 26 individuals, divided into control and 
intervention groups, and found that patients undergoing 
NMES applied to the quadriceps muscle as well as the 
control group showed decreased muscle mass. Howe-
ver, this decrease was significantly lower in the NMES 
group, suggesting that NMES may have a protective 
effect against muscle wasting. Nevertheless, Poulsen 
et al. (29) applied NMES to the quadriceps muscle, 
using the contralateral limb as a control, and found 
no difference in muscle mass between the stimulated 
and non-stimulated side, as assessed by computed 
tomography. Gruther et al. (30) used ultrasound to 
investigate the effects of NMES on the thickness of 
the quadriceps muscle during the acute phase (less than 
7 days of hospitalization) and in the long term (more 
than 14 days after admission) in critically ill patients. 
The authors found increased thickness only for long-
term patients who started NMES after 2 weeks of ICU 
admission. However, there was no increased thickness 
in acute patients. This is in agreement with the present 
findings, which demonstrated no change in muscle 
mass even when the NMES protocol was started early 
(up to 48 h of ICU admission).
As for the secondary outcomes, there was no 
statistically significant difference between groups 
in diaphragm thickness or inhaling and exhaling 
diaphragmatic motion. There was a significant dif-
ference only in the number of days of ICU stay, with 
a shorter stay in the intervention group compared 
with the conventional group. The implementation 
of early mobilization programmes, which is the type 
of intervention proposed in our study, may lead to a 
reduction in length of ICU stay (31). The use of IMV 
may also induce diaphragmatic dysfunction, reducing 
the patients’ force generation capacity and mobility 
(32, 33). Martin et al. (34) used physical therapy to 
assess the improvement in peripheral and respiratory 





















in mean (95% CI)
Adjusted 
p-valueb
IDM 0.36 (0.18) 0.47 (0.18) 0.11 (–0.05 to 0.26) 0.397 0.46 (0.29) 0.51 (0.37) 0.05 (–0.23 to 0.33) 1.000 0.08 (–0.04 to 0.54) 0.081
EDM 0.23 (0.15) 0.31 (0.14) 0.08 (–0.06 to 0.22) 0.818 0.35 (0.27) 0.31 (0.32) –0.04 (–0.28 to 0.20) 1.000 0.12 (–0.03 to 0,.34 0.268
DT 0.28 (0.18) 0.27 (0.18) –0.01 (–0.11 to 0.08) 1.000 0.20 (0.05) 0.18 (0.05) –0.02 (–0.05 to 0.03) 1.000 0.00 (–0.07 to 0.05) 0.718
aIntra-group effect using a generalized estimating equations (GEE) model with Bonferroni’s correction; bintergroup effect using a generalized estimating equations 
(GEE) model with Bonferroni’s correction adjusted for APACHE II, sepsis end ICU stay. All ultrasound measurements were expressed in cm. 
IDM: inhaling diaphragmatic motion; EDM: exhaling diaphragmatic motion; DT: diaphragm muscle thickness; 95% CI: 95% confidence interval; SD: standard 
deviation; ICU: intensive care unit.
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muscle strength and functional status of mechanically 
ventilated patients, and found a positive correlation 
between upper limb strength and ventilation weaning 
time. However, in our study, there was no statistically 
significant difference regarding days of IMV and re-
intubation rate. In a previous study conducted by our 
research group, we found increased inspiratory and 
expiratory muscle strength by administering NMES 
using Russian current in the rectus abdominis and 
abdominal oblique muscle in inpatients with COPD 
compared with the control group (19).
The most prevalent ICU admission diagnosis in our 
study was sepsis (60%). Studies conducted in ICUs 
involving the use of NMES have demonstrated that 
the most common diagnoses on admission are sepsis, 
COPD, and trauma (28, 30, 35). Sepsis is known to 
generate a reaction of protein hypercatabolism in the 
muscles, contributing to loss of muscle mass. Loss 
of muscle mass is partially attributed to sepsis and to 
multiple organ dysfunction syndrome, use of drugs, 
such as neuromuscular blockers, and immobilization 
(36). Therefore, we adjusted the outcomes by dividing 
our patients into septic and non-septic, and the results 
were statistically significant even after the adjustment. 
The re-intubation rate in the intervention group was 
25% against 38% in the conventional group. Routsi et 
al. (37) applied NMES to the quadriceps and peroneus 
longus muscles of critically ill patients and found redu-
ced weaning time in the intervention group. However, 
in agreement with our findings, there was no significant 
difference in the re-intubation rate between groups. 
Conversely, a study conducted by Abu-Khaber et al. 
(38), evaluating the prevention of muscle weakness and 
facilitation of weaning from mechanical ventilation in 
critically ill patients using NMES in the quadriceps 
muscle and starting the protocol within the first 2 days 
of mechanical ventilation, reported unclear conclusions 
about the role of NMES in facilitating the weaning 
process. In addition, the number of days on mechanical 
ventilation was lower in the NMES group compared 
with sham stimulation, but the statistical significance 
level was very low (p = 0.048). 
In our study, APACHE II score was similar in both 
groups. In a systematic review on the use of NMES in 
intensive care, Parry et al. (39) concluded that patients 
with an APACHE II score greater than 20 did not bene-
fit from NMES to preserve muscle mass. Conversely, 
individuals with an APACHE II score lower than 16 
showed better muscle response to NMES. Such nega-
tive results may be linked to the correlation between 
NMES intensity and disease severity, because the ex-
citability of muscle tissue in this condition may induce 
dysfunctions of the muscle membrane compromising 
its contraction and increasing catabolism, thus enhan-
cing loss of muscle mass (29). However, our findings 
demonstrated positive effects in terms of preservation 
of muscle mass, even after adjusting the values  for 
patients with APACHE II score > 25 and < 25, which 
suggests that NMES may prevent loss of muscle mass 
even in patients with high APACHE II score.
The mean NMES duration in the current study was 
5 days in the intervention group. In comparison with 
our study, the duration of treatment was significantly 
longer (in days) in previous studies using NMES in the 
peripheral muscles of critically ill patients; therefore, 
these studies showed positive results regarding muscle 
mass gain (28, 29). The study by Routsi et al. (37) 
used 55 min/day of NMES, demonstrating positive 
results in terms of muscle mass and development of 
polyneuropathy. In our study, we initially used 30 min 
of NMES in the rectus abdominis and chest muscles, 
adding 1 min every 2 days, and found positive results 
in terms of muscle thickness. Such findings suggest 
that the initial daily use of 30 min of NMES benefits 
critically ill patients.
The parameters used in the NMES protocol of our 
study were designed and established by the research 
team with great theoretical knowledge about the prin-
ciples of NMES. Therefore, we were able to achieve 
the desired muscle fibre recruitment in these muscle 
groups, with the purpose of recruiting fast and slow 
twitch fibres, based on the positive results described 
previously in the literature, using parameters very si-
milar to the ones used in our study, in order to increase 
peripheral muscle strength and the potential benefits 
related to the preservation of the muscle mass of cri-
tically ill patients (23, 24, 39).
We decided to use ultrasound to evaluate muscle 
and diaphragmatic behaviour in the administration of 
NMES because it is a valuable tool in the management 
of ICU patients. Ultrasound examination makes it pos-
sible to quantify diaphragmatic motion and accurately 
assess muscle atrophy (40). The choice of this tool 
appears to be more accurate for muscle assessment in 
ICU patients (28) and overcomes many of the problems 
associated with anthropometric and body composition 
measures, such as oedema, which may be a source of 
bias when assessing muscle thickness (30). Currently, 
ultrasound is the most reliable method and its validity 
is well established in intensive care (39).
Our findings are limited by a relatively small number 
of patients who underwent NMES sessions. Further-
more, sedation and the use of vasopressor drugs might 
have affected microcirculation in these patients.
Further studies with larger samples might provide 
subgroup analysis to identify the potential beneficial 
effects of NMES when applied to the muscles involved 
in respiratory mechanics in different populations, since 
the initial results of this approach are positive in the pre-










































47NMES to preserve muscle thickness in critically ill patients
In conclusion, there was no change in rectus abdomi-
nis and chest muscle thickness in critically ill patients 
in the intervention group (neuromuscular electrical 
stimulation+conventional physical therapy); however, 
we found a significant decrease in these measures in 
the conventional group (sham neuromuscular electrical 
stimulation + conventional physical therapy). In addi-
tion, the length of ICU stay was significantly shorter 
in the group receiving active NMES. 
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